LRMR vs BNTC
Comparison between Larimar Therapeutics Inc (LRMR, Company) and Benitec Biopharma Inc (BNTC, Company).
Both LRMR and BNTC are from the Healthcare sector.
5-Year PerformanceLRMR has outperformed BNTC, delivering a return of -16.1% compared to -32.5%
LRMR vs BNTC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LRMR vs BNTC - Historical Returns
Returns include dividend reinvestment.
LRMR vs BNTC - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | LRMR | BNTC |
|---|---|---|
| 2026 | +0.00% | -11.16% |
| 2025 | -4.99% | +11.51% |
| 2024 | -24.27% | +286.01% |
| 2023 | +13.75% | +8.57% |
| 2022 | -61.58% | -93.80% |
| 2021 | -50.95% | -21.56% |
| 2020 | +60.74% | -56.99% |
| 2019 | -78.06% | -66.00% |
| 2018 | +3.34% | -48.39% |
| 2017 | +42.59% | +93.46% |
| 2016 | -50.23% | -63.48% |
| 2015 | -79.66% | -49.56% |
| 2014 | +56.15% | N/A |
LRMR vs BNTC Drawdown Comparison
The maximum drawdown for LRMR was -99.75%, occurring on Aug 5, 2022. This drawdown has not yet recovered.
The maximum drawdown for BNTC was -99.91%, occurring on Aug 8, 2023. This drawdown has not yet recovered.
The current LRMR drawdown is -99.44%. The current BNTC drawdown is -99.48%.
| Rank | LRMR | BNTC |
|---|---|---|
| #1 | -99.75% Mar 19, 2015 - Aug 5, 2022 | -99.91% Aug 20, 2015 - Aug 8, 2023 |
| #2 | -22.18% Sep 2, 2014 - Oct 30, 2014 | N/A |
| #3 | -16.93% Jan 8, 2015 - Jan 26, 2015 | N/A |
| #4 | -12.88% Jun 23, 2014 - Aug 28, 2014 | N/A |
| #5 | -12.79% Oct 30, 2014 - Nov 24, 2014 | N/A |
| #6 | -11.17% Jan 27, 2015 - Feb 23, 2015 | N/A |
| #7 | -10.00% Feb 23, 2015 - Mar 10, 2015 | N/A |
| #8 | -8.22% Nov 28, 2014 - Dec 17, 2014 | N/A |
| #9 | -3.27% Dec 26, 2014 - Jan 6, 2015 | N/A |
| #10 | -1.18% Mar 12, 2015 - Mar 16, 2015 | N/A |
| #11 | -0.99% Aug 28, 2014 - Sep 2, 2014 | N/A |
Correlation
Correlation between LRMR and BNTC is 0.87 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks